The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies. Academic Article uri icon

Overview

publication date

  • January 1, 2002

Research

keywords

  • Antineoplastic Agents
  • Carrier Proteins
  • Protein Kinase C

Identity

Scopus Document Identifier

  • 0036375921

Digital Object Identifier (DOI)

  • 10.1016/s0065-2571(01)00029-2

PubMed ID

  • 12123714

Additional Document Info

volume

  • 42